Trials / NCT03396042
Natural History Study of CEP290-Related Retinal Degeneration
Completed Observational Natural history / observational
- Sponsor
- Editas Medicine, Inc.
- Treatment
- Not listed
- Gene
- CEP290
- Conditions
- Blindness, Leber Congenital Amaurosis 10, Vision Disorders, Eye Diseases, Eye Diseases, Hereditary, Eye Disorders Congenital, Retinal Disease, Retinal Degeneration
- Ages
- 3 Years to 99 Years
- Enrollment
- 26 participants
- Started
- 2017-12-17
- Main results expected
- 2022-05-06
- Results posted
- Not yet
- Record last updated
- 2022-05-19
What the study is testing
A prospective natural history study with systematic assessments and uniform follow-up to provide a high-quality dataset for assisting in the design of future clinical treatment trials involving patients with CEP290-related retinal degeneration caused by the common intron 26 mutation.
Where it runs
France (1)
- Universite Pierre et Marie Curie, Paris
Germany (1)
- Universitaetsklinikum Giessen and Marburg GmbH, Giessen
Netherlands (1)
- Radboud Universitair Medisch Centrum, Nijmegen, Gelderland
United States (4)
- Bascom Palmer Eye Institute, Miami, Florida
- Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
- W.K. Kellogg Eye Center, Ann Arbor, Michigan
- Casey Eye Institute - OHSU, Portland, Oregon